Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
![Tert-Butyl bicyclo[2.2.2]phosphorothionate (TBPS)](https://www.pharmacompass.com/image/drug/104781.png)
1. T-butylbicyclophosphorothionate
2. Tbps
3. Tert-bbcp
1. Tbps
2. 70636-86-1
3. Tert-butyl Bicyclo[2.2.2]phosphorothionate
4. T-butylbicyclophosphorothionate
5. 4-tert-butyl-1-sulfanylidene-2,6,7-trioxa-1lambda5-phosphabicyclo[2.2.2]octane
6. 2,6,7-trioxa-1-phosphabicyclo(2.2.2)octane, 4-(1,1-dimethylethyl)-, 1-sulfide
7. 2,6,7-trioxa-1-phosphabicyclo[2.2.2]octane,4-(1,1-dimethylethyl)-, 1-sulfide
8. 2,6,7-trioxa-1-phosphabicyclo[2.2.2]octane, 4-(1,1-dimethylethyl)-, 1-sulfide
9. Tert-butyl-bicyclo[2.2.2]
10. Tert-butyl Bicyclo[2 2 2]phosphorothionate
11. 2,6,7-trioxa-1-phosphabicyclo(2.2.2)octane, 4-tert-butyl-, 1-sulfide
12. Biomol-nt_000268
13. Bpbio1_000816
14. Chembl485673
15. Gtpl4320
16. Schembl7733832
17. Dtxsid7058464
18. Tert-butylbicyclophosphorothioic Acid
19. 4-tert-butyl-2,6,7-trioxa-1$l^{5}-phosphabicyclo[2.2.2]octane-1-thione
20. Phosphorothioic Acid, Cyclic O,o,o-ester With 2-(tert-butyl)-2-(hydroxymethyl)-1,3-propanediol
21. C19930
22. Tert-butyl Bicyclo[2.2.2]phosphorothionate, Solid
23. Q27088943
24. Tert-butyl Bicyclo[2.2.2]phosphorothionate,tbps
| Molecular Weight | 222.24 g/mol |
|---|---|
| Molecular Formula | C8H15O3PS |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 59.8 |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 240 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Convulsants
Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)
ABOUT THIS PAGE
31
PharmaCompass offers a list of Tert-Butyl bicyclo[2.2.2]phosphorothionate (TBPS) API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tert-Butyl bicyclo[2.2.2]phosphorothionate (TBPS) manufacturer or Tert-Butyl bicyclo[2.2.2]phosphorothionate (TBPS) supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tert-Butyl bicyclo[2.2.2]phosphorothionate (TBPS) manufacturer or Tert-Butyl bicyclo[2.2.2]phosphorothionate (TBPS) supplier.
PharmaCompass also assists you with knowing the Tert-Butyl bicyclo[2.2.2]phosphorothionate (TBPS) API Price utilized in the formulation of products. Tert-Butyl bicyclo[2.2.2]phosphorothionate (TBPS) API Price is not always fixed or binding as the Tert-Butyl bicyclo[2.2.2]phosphorothionate (TBPS) Price is obtained through a variety of data sources. The Tert-Butyl bicyclo[2.2.2]phosphorothionate (TBPS) Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Biomol-NT_000268 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Biomol-NT_000268, including repackagers and relabelers. The FDA regulates Biomol-NT_000268 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Biomol-NT_000268 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Biomol-NT_000268 supplier is an individual or a company that provides Biomol-NT_000268 active pharmaceutical ingredient (API) or Biomol-NT_000268 finished formulations upon request. The Biomol-NT_000268 suppliers may include Biomol-NT_000268 API manufacturers, exporters, distributors and traders.
Biomol-NT_000268 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Biomol-NT_000268 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Biomol-NT_000268 GMP manufacturer or Biomol-NT_000268 GMP API supplier for your needs.
A Biomol-NT_000268 CoA (Certificate of Analysis) is a formal document that attests to Biomol-NT_000268's compliance with Biomol-NT_000268 specifications and serves as a tool for batch-level quality control.
Biomol-NT_000268 CoA mostly includes findings from lab analyses of a specific batch. For each Biomol-NT_000268 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Biomol-NT_000268 may be tested according to a variety of international standards, such as European Pharmacopoeia (Biomol-NT_000268 EP), Biomol-NT_000268 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Biomol-NT_000268 USP).
